Company Overview
- Headquarters
- 2485 Holly Oak, Danville CA
- Website
- bryologyx.com
- Employees
- 6
- Industry
- BioTech/Drugs
Financials & Stats
Revenue
$3B
Who is BryoLogyx
BryoLogyx is a biotechnology company based in Danville, California. The company is privately held and employs 6 people. BryoLogyx focuses on developing a new class of drugs to improve the effectiveness of cancer immunotherapies. Their approach leverages bryostatin, a natural product that stimulates tumor antigen production, enhancing the immune response to cancer. The company has developed a synthetic production method for bryostatin and its analogs, making it commercially viable for development. BryoLogyx has secured exclusive rights from Stanford University to use this synthetic production method for cancer treatment and other applications, including inflammatory, autoimmune, and infectious diseases (excluding neurological, CNS diseases, and psychiatric disorders). BryoLogyx plans to conduct clinical studies in collaboration with the National Cancer Institute. BryoLogyx's website can be found at bryologyx.com.
Companies Similar to BryoLogyx
Analyze industry trends and opportunities by examining competitors and companies comparable to BryoLogyx, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 3M | Arvada, CO | |||
| 3M | 6 | Star Valley Ranch, WY | ||
| 3M | 4 | Ann Arbor, MI | 2006 | |
| 3M | 3 | San Diego, CA | ||
| 3M | 3 | New York, NY |